Clinical Trials List
Protocol Number201907017MIPD, RISE-HN
2019-09-18 - 2022-12-31
Phase I
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- RUEY-LONG HONG Division of Hematology & Oncology
- 陳贈成 Division of Otolaryngology
- 陳俊男 Division of Otolaryngology
- 廖斌志 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
13 participants
